ESR1 and Obesity: The comorbidity of obesity is reported to be a risk factor of BC in postmenopausal women by affecting the estrogen receptor signaling, such as excessive local production of estrogens in adipose tissues, production of adipokines and inflammatory cytokines and hypercholesterolemia [226,227].